Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team to fuel new scientific discovery, no matter how challenging. And we won’t stop until all of the cells’ secrets are revealed.

10x Genomics

 #Singlecellspatial lets researchers like Dr. Nick Banovich take their research to the next level by offering gross tissue morphology and single-molecule RNA transcript detection at subcellular resolution on a single section. Hear why he was excited to get his hands on Xenium #InSitu in a quick clip below, then watch the full webinar for more! https://lnkd.in/gurVFX-r

We just wrapped up an amazing, empowering week in Palm Springs with our global commercial team! 🌴🎉 The week unfolded with a focus on innovation and professional development featuring keynote speakers and breakout sessions. Did we mention we also had a ton of fun?! We had an array of team-building activities, from early morning sessions of pickleball and yoga, to carnival booth games, to an "Old Hollywood''-themed awards celebration and dinner. A HUGE thanks to our amazing commercial team who brought collaborative energy, shared powerful insights, and strengthened professional relationships. 🙌 

Hippos eat more than 80 lbs of food a day to support their massive size. Organs use the Hippo pathway—which controls organ size by regulating cell proliferation and apoptosis. #Cancer often takes advantage of the Hippo pathway to boost tumor growth, but therapeutically targeting it is challenging. Check out this study to see how Genentech researchers used #singlecell methods to measure the efficacy of their small molecule inhibitor candidate! 

Heart defects are the leading cause of fetal death, but, historically, research on this important subject has been difficult for a number of reasons, including the inaccessibility of human embryonic samples and the limitations of in vitro models. However, in honor of #AmericanHeartMonth, we’re highlighting a recent paper that uncovered new insights into underlying defects in the developing human heart, using our #singlecell Flex assay to generate compartment-specific, in vivo–like gene expression profiles. Read the paper!

What do mini-kidneys, tiny tumors, and little livers have in common? They were highlighted in one of our top blogs from 2023! Read the blog to learn how scientists are using #organoid models and high-resolution #singlecell analysis to identify druggable disease pathways, screen drugs, model drug metabolism, and explore patient-specific therapeutic responses! 

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

HSTS

DNSSEC

Content Delivery Network

Global Site Tag

Font Awesome

reCAPTCHA

Cloudflare CDN

Bryan Roberts

Ben Hindson

Chief Scientific Officer, Co-founder, President

Serge Saxonov

Co-founder & CEO

Mike Lucero

Head Of Strategic Marketing

Jonathan Schimmel

Vice President, Global Support and Sales Operations

Miguel Feldens

Director, Productivity Engineering

Danae Van Oene

Vice President and General Manager, Americas Region

Sumeet Gagneja

Vice President, Corporate Controller

Fergus Chan

Director of Product Management

Medical Public Companies With Less Than $1B in Revenue

Biotechnology Public Companies With More Than 500 Employees

San Francisco Bay Area Companies With More Than 500 Employees

Western US Companies With More Than $1M in Revenue (Top 10K)

10x Genomics is creating revolutionary DNA sequencing technology to help researchers better identify subtle variations that are overlooked by technologies that shred biological samples into tiny fragments before sequencing the short stretches and using computers to assembling them into a genome.

Post-IPO Equity - 10X Genomics

Meritech Capital Partners

Series D - 10X Genomics

Fidelity

Series C - 10X Genomics

Foresite Capital

Series B - 10X Genomics

Series A - 10X Genomics

Silicon Valley Bank

Seed Round - 10X Genomics

Computer and Software Products and Electrical and Scientific Products

Pleasanton

California

United States

North America

10X Genomics

Spatial Genomics and Transcriptomics Research Analysis Report 2024-2030: Emergence of High-Throughput Sequencing Platforms Fuels Market Growth

Sample Preparation Market projected to achieve a CAGR of 4.54% to reach US$7,760.027 million by 2030

10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference

Spatial Genomics and Transcriptomics Market Analysis, 2018-2032: Trends, Opportunities, Challenges, Regional Dynamics, Value Chain Analysis, Competitive Landscape and Industry Developments

Spatial Transcriptomics: A window into disease

These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results

Goldman Sachs Maintains Sell on 10x Genomics,...

BioMarin price target lowered by $12 at Citi, here's why

Allows whole transcriptome analysis at single cell-scale resolution with continuous tissue coverage, using probe-based chemistry and Visium CytAssist-enabled workflow.

Provides transcriptomic profiling at single cell resolution, with options for multiomic analysis including cell surface proteins and CRISPR perturbations.

Enables multiomic analysis of the immune system at single cell resolution, including gene expression, cell surface proteins, and full-length paired BCR and TCR sequences.

Targets hundreds of single-molecule RNA with subcellular resolution in tissue sections, refining biological insights through single cell and spatial analyses.

China

Asia

Belgium

Europe

Germany

United Kingdom

HTML5

Wistia

Google Fonts

Lead generation and appointment setting

Bootstrap

jQuery

Adobe Fonts

F5 NGINX

Google Drive

A platform for asking and answering bioinformatics questions

biostars.org

Website for the Satija Lab at the New York Genome Center and NYU

satijalab.org

A preprint server for the biological sciences

biorxiv.org

Publisher of the journal Cell and other scientific publications

cell.com

Algorithmic Biologics

Biotechnology company specializing in single-cell sequencing

Singleron Biotechnologies

Company focused on genomics and sequencing technologies

Singular Genomics

Provider of instruments and software for life science research

Molecular Devices LLC

Company specializing in food delivery of imperfect produce

Imperfect Produce

10x Genomics is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. The company's innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

news impact assignment basic	general	Mar 8, 2024 8:37 AM	699d905c
public peers	general
news daily refresh	general	Dec 4, 2024 2:16 PM	ca313009
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 8:37 AM	15a3177e
company summary	general
signals	general	Mar 8, 2024 8:37 AM	ef080a7b
crunchbase trigger	general	Nov 25, 2024 9:06 AM	405a2263
crunchbase profile	general	Nov 25, 2024 11:36 AM	ecb8fa12
li profile	general	Mar 8, 2024 8:37 AM	ac1a2188
translate crunchbase fundingrounds	general	Nov 25, 2024 2:15 PM	a20f44fe
peers	general	Mar 8, 2024 8:37 AM	ed42a870
news basic	general	Dec 4, 2024 2:13 PM	7abe5988
bundesanzeiger	filings	Mar 8, 2024 8:37 AM	96604ab5
financials download nd	financials
private financials	financials

COM:10XGENOMICS

10x Genomics, Inc.

Last Close

13.29

22/11 21:00

Market Cap

1.88B

Beta: -

Volume Today

5.63M

Avg: -